Gemmy Cheung, Chui Ming <br/><br/>
Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.  [electronic resource] 

 -  American journal of ophthalmology  Feb 2013 
 - 295-304.e1 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2012.08.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Choroid--blood supply<br/>Choroid Diseases--diagnosis<br/>Coloring Agents<br/>Combined Modality Therapy<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fovea Centralis<br/>Humans<br/>Indocyanine Green<br/>Intravitreal Injections<br/>Laser Therapy<br/>Lasers, Excimer--therapeutic use<br/>Male<br/>Middle Aged<br/>Polyps--diagnosis<br/>Prospective Studies<br/>Ranibizumab<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology